Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and Poxvirus research and outbreaks.
The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Antibody Titers against Mpox Virus after Vaccination
Homologous and Heterologous Covid-19 Booster Vaccinations
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides